Skip to content

Rho GTPase-activating protein 26 (ARHGAP26)

Homo sapiens — UniProt Q9UNA1

Gene: ARHGAP26Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Rho GTPase-activating protein 26 (ARHGAP26) is a protein from Homo sapiens identified by UniProt accession Q9UNA1, 814 residues long. MolForge cross-references it against 0 known binders and 289 disease associations.

  • UniProt accession: Q9UNA1; gene symbol ARHGAP26.
  • Organism: Homo sapiens.
  • Length: 814 amino acids.
  • Top disease associations (Open Targets): Juvenile Myelomonocytic Leukemia, eosinophil count and coronary artery disease.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameRho GTPase-activating protein 26
UniProt accessionQ9UNA1
GeneARHGAP26
OrganismHomo sapiens
Length814 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (289)

Diseases linked to this target (Open Targets).

  • Juvenile Myelomonocytic Leukemia · score 0.47
  • eosinophil count · score 0.44
  • coronary artery disease · score 0.38
  • pancreatic ductal adenocarcinoma · score 0.37
  • pancreatic carcinoma · score 0.37
  • gastric carcinoma · score 0.37
  • prostate adenocarcinoma · score 0.37
  • lymphoid neoplasm · score 0.37
  • kidney neoplasm · score 0.37
  • esophageal adenocarcinoma · score 0.37

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9UNA1-F1alphafoldPREDICTED77.30—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9UNA1.

Amino-acid sequence (814 residues)

MGLPALEFSD CCLDSPHFRE TLKSHEAELD KTNKFIKELI KDGKSLISAL KNLSSAKRKF ADSLNEFKFQ CIGDAETDDE MCIARSLQEF ATVLRNLEDE RIRMIENASE VLITPLEKFR KEQIGAAKEA KKKYDKETEK YCGILEKHLN LSSKKKESQL QEADSQVDLV RQHFYEVSLE YVFKVQEVQE RKMFEFVEPL LAFLQGLFTF YHHGYELAKD FGDFKTQLTI SIQNTRNRFE GTRSEVESLM KKMKENPLEH KTISPYTMEG YLYVQEKRHF GTSWVKHYCT YQRDSKQITM VPFDQKSGGK GGEDESVILK SCTRRKTDSI EKRFCFDVEA VDRPGVITMQ ALSEEDRRLW MEAMDGREPV YNSNKDSQSE GTAQLDSIGF SIIRKCIHAV ETRGINEQGL YRIVGVNSRV QKLLSVLMDP KTASETETDI CAEWEIKTIT SALKTYLRML PGPLMMYQFQ RSFIKAAKLE NQESRVSEIH SLVHRLPEKN RQMLQLLMNH LANVANNHKQ NLMTVANLGV VFGPTLLRPQ EETVAAIMDI KFQNIVIEIL IENHEKIFNT VPDMPLTNAQ LHLSRKKSSD SKPPSCSERP LTLFHTVQST EKQEQRNSII NSSLESVSSN PNSILNSSSS LQPNMNSSDP DLAVVKPTRP NSLPPNPSPT SPLSPSWPMF SAPSSPMPTS STSSDSSPVR SVAGFVWFSV AAVVLSLARS SLHAVFSLLV NFVPCHPNLH LLFDRPEEAV HEDSSTPFRK AKALYACKAE HDSELSFTAG TVFDNVHPSQ EPGWLEGTLN GKTGLIPENY VEFL

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with ARHGAP26?

The strongest Open Targets associations for ARHGAP26 are Juvenile Myelomonocytic Leukemia, eosinophil count, coronary artery disease, pancreatic ductal adenocarcinoma and pancreatic carcinoma.

How long is the ARHGAP26 protein?

The Homo sapiens ARHGAP26 protein (UniProt Q9UNA1) is 814 amino acids long.

Browse: Targets: A · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Rho GTPase-activating protein 26 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9UNA1
GeneARHGAP26
OrganismHomo sapiens
Length814
Binders0
Diseases289
View on UniProt